ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+27.5%
5Y CAGR+19.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+27.5%/yr
vs +23.3%/yr prior
5Y CAGR
+19.4%/yr
Recent acceleration
Acceleration
+4.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.07B+11.9%
2024$957.80M+31.8%
2023$726.44M+40.4%
2022$517.24M+6.8%
2021$484.14M+9.6%
2020$441.75M+30.3%
2019$339.08M+51.5%
2018$223.81M+79.2%
2017$124.90M+620.7%
2016$17.33M-